Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?

por Bowsher, Ronald R., Devanarayan, Viswanath
Publicado 2020

ODP178 Development and Validation of a Noncompetitive Immunoassay Optimized for the Assessment of Pharmacokinetics of Biologically Active Efruxifermin in Humans

por Hurst, Jacob, Johnson, Derrick, Tillman, Erik, Rolph, Timothy, Thystrup, Jennifer, Bowsher, Ronald
Publicado 2022

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines

por Humphrey, Shannon, Dover, Jeffrey S, Bowsher, Ronald R, Clancy, Amanda, Liu, Yan, Prawdzik, Gregg, Gallagher, Conor J
Publicado 2023

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials

por Gallagher, Conor J., Bowsher, Ronald R., Clancy, Amanda, Dover, Jeffrey S., Humphrey, Shannon, Liu, Yan, Prawdzik, Gregg
Publicado 2023

Generation of Affinity Purified Antibody Reagents for Specific Determination of Efruxifermin in Biological Matrices

por Kinne, Adam S, Abdeen, Sanofar J, Parmer, Elijah S, Thystrup, Jennifer A, Tillman, Erik J, Rolph, Timothy P, Bowsher, Ronald R
Publicado 2021

Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain

por Johnson, Derrick, Simmons, Erica, Abdeen, Sanofar, Kinne, Adam, Parmer, Elijah, Rinker, Sherri, Thystrup, Jennifer, Ramaswamy, Swarna, Bowsher, Ronald R.
Publicado 2021

Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 s...

por Sun, Bin, Sengupta, Nilanjan, Rao, Anita, Donnelly, Charles, Waichale, Vinit, Roy, Arnab Sinha, Ramaswamy, Shilpa, Pathak, Divya, Bowsher, Ronald R., Raiter, Yaron, Aubonnet, Patrick, Barve, Abhijit
Publicado 2021

An Integrated Analysis of Dostarlimab Immunogenicity

por Lu, Sharon, Bowsher, Ronald R., Clancy, Amanda, Rosen, Amy, Zhang, Mingxuan, Yang, Ying, Koeck, Kathleen, Gao, Minggeng, Potocka, Elizabeth, Guo, Wei, Jen, Kai Yu, Im, Ellie, Milton, Ashley
Publicado 2021

FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein

por Miller, Christina J., McGinnis, Jennifer E., Martinez, Michael J., Wang, Guangli, Zhou, Jian, Simmons, Erica, Amet, Tohti, Abdeen, Sanofar J., Van Huysse, James W., Bowsher, Ronald R., Kay, Brian K.
Publicado 2021

Anti-drug Antibody Validation Testing and Reporting Harmonization

por Myler, Heather, Pedras-Vasconcelos, João, Phillips, Kelli, Hottenstein, Charles Scott, Chamberlain, Paul, Devanaryan, Viswanath, Gleason, Carol, Goodman, Joanne, Manning, Marta Starcevic, Purushothama, Shobha, Richards, Susan, Shen, Honglue, Zoghbi, Jad, Amaravadi, Lakshmi, Barger, Troy, Bowen, Steven, Bowsher, Ronald R., Clements-Egan, Adrienne, Geng, Dong, Goletz, Theresa J., Gunn, George R., Hallett, William, Hodsdon, Michael E., Janelsins, Brian M., Jawa, Vibha, Kamondi, Szilard, Kirshner, Susan, Kramer, Daniel, Liang, Meina, Lindley, Kathryn, Liu, Susana, Liu, ZhenZhen, McNally, Jim, Mikulskis, Alvydas, Nelson, Robert, Ahbari, Mohsen Rajabi, Qu, Qiang, Ruppel, Jane, Snoeck, Veerle, Song, An, Yan, Haoheng, Ware, Mark
Publicado 2021